Supply Chain | April 08, 2026
Merck expands Bengaluru plant to strengthen global filtration supply chain
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
